Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Anti-fungal Drugs Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Powder
  • 1.4.3 Ointment
  • 1.4.4 Tablet
  • 1.4.5 Other
• 1.5 Market by Application
  • 1.5.1 Global Anti-fungal Drugs Market Share by Application (2019-2025)
  • 1.5.2 Hospital
  • 1.5.3 Retail Pharmacy
  • 1.5.4 Online Pharmacy
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Anti-fungal Drugs Market Size
• 2.2 Anti-fungal Drugs Growth Trends by Regions
  • 2.2.1 Anti-fungal Drugs Market Size by Regions (2019-2025)
  • 2.2.2 Anti-fungal Drugs Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Anti-fungal Drugs Market Size by by Players
  • 3.1.1 Global Anti-fungal Drugs Revenue by by Players (2014-2019)
  • 3.1.2 Global Anti-fungal Drugs Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Anti-fungal Drugs Market Concentration Ratio (CR5 and HHI)
• 3.2 Anti-fungal Drugs Key Players Head office and Area Served
• 3.3 Key Players Anti-fungal Drugs Product/Solution/Service
• 3.4 Date of Enter into Anti-fungal Drugs Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Anti-fungal Drugs Market Size by Type (2014-2019)
• 4.2 Global Anti-fungal Drugs Market Size by Application (2014-2019)

5 North America

• 5.1 North America Anti-fungal Drugs Market Size (2014-2019)
• 5.2 Anti-fungal Drugs Key Players in North America
• 5.3 North America Anti-fungal Drugs Market Size by Type
• 5.4 North America Anti-fungal Drugs Market Size by Application

6 Europe

• 6.1 Europe Anti-fungal Drugs Market Size (2014-2019)
• 6.2 Anti-fungal Drugs Key Players in Europe
• 6.3 Europe Anti-fungal Drugs Market Size by Type
• 6.4 Europe Anti-fungal Drugs Market Size by Application

7 China

• 7.1 China Anti-fungal Drugs Market Size (2014-2019)
• 7.2 Anti-fungal Drugs Key Players in China
• 7.3 China Anti-fungal Drugs Market Size by Type
• 7.4 China Anti-fungal Drugs Market Size by Application

8 Japan

• 8.1 Japan Anti-fungal Drugs Market Size (2014-2019)
• 8.2 Anti-fungal Drugs Key Players in Japan
• 8.3 Japan Anti-fungal Drugs Market Size by Type
• 8.4 Japan Anti-fungal Drugs Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Anti-fungal Drugs Market Size (2014-2019)
• 9.2 Anti-fungal Drugs Key Players in Southeast Asia
• 9.3 Southeast Asia Anti-fungal Drugs Market Size by Type
• 9.4 Southeast Asia Anti-fungal Drugs Market Size by Application

10 India

• 10.1 India Anti-fungal Drugs Market Size (2014-2019)
• 10.2 Anti-fungal Drugs Key Players in India
• 10.3 India Anti-fungal Drugs Market Size by Type
• 10.4 India Anti-fungal Drugs Market Size by Application

11 Central & South America

• 11.1 Central & South America Anti-fungal Drugs Market Size (2014-2019)
• 11.2 Anti-fungal Drugs Key Players in Central & South America
• 11.3 Central & South America Anti-fungal Drugs Market Size by Type
• 11.4 Central & South America Anti-fungal Drugs Market Size by Application

12 International Players Profiles

• 12.1 Abbott Laboratories
  • 12.1.1 Abbott Laboratories Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Anti-fungal Drugs Introduction
  • 12.1.4 Abbott Laboratories Revenue in Anti-fungal Drugs Business (2014-2019))
  • 12.1.5 Abbott Laboratories Recent Development
• 12.2 Astellas Pharma
  • 12.2.1 Astellas Pharma Company Details
  • 12.2.2 Company Description and Business Overview
  • 12.2.3 Anti-fungal Drugs Introduction
  • 12.2.4 Astellas Pharma Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.2.5 Astellas Pharma Recent Development
• 12.3 Bayer
  • 12.3.1 Bayer Company Details
  • 12.3.2 Company Description and Business Overview
  • 12.3.3 Anti-fungal Drugs Introduction
  • 12.3.4 Bayer Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.3.5 Bayer Recent Development
• 12.4 GlaxoSmithKline
  • 12.4.1 GlaxoSmithKline Company Details
  • 12.4.2 Company Description and Business Overview
  • 12.4.3 Anti-fungal Drugs Introduction
  • 12.4.4 GlaxoSmithKline Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.4.5 GlaxoSmithKline Recent Development
• 12.5 Glenmark
  • 12.5.1 Glenmark Company Details
  • 12.5.2 Company Description and Business Overview
  • 12.5.3 Anti-fungal Drugs Introduction
  • 12.5.4 Glenmark Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.5.5 Glenmark Recent Development
• 12.6 Kramer Laboratories
  • 12.6.1 Kramer Laboratories Company Details
  • 12.6.2 Company Description and Business Overview
  • 12.6.3 Anti-fungal Drugs Introduction
  • 12.6.4 Kramer Laboratories Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.6.5 Kramer Laboratories Recent Development
• 12.7 Merck
  • 12.7.1 Merck Company Details
  • 12.7.2 Company Description and Business Overview
  • 12.7.3 Anti-fungal Drugs Introduction
  • 12.7.4 Merck Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.7.5 Merck Recent Development
• 12.8 Novartis
  • 12.8.1 Novartis Company Details
  • 12.8.2 Company Description and Business Overview
  • 12.8.3 Anti-fungal Drugs Introduction
  • 12.8.4 Novartis Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.8.5 Novartis Recent Development
• 12.9 Pfizer
  • 12.9.1 Pfizer Company Details
  • 12.9.2 Company Description and Business Overview
  • 12.9.3 Anti-fungal Drugs Introduction
  • 12.9.4 Pfizer Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.9.5 Pfizer Recent Development
• 12.10 SCYNEXIS
  • 12.10.1 SCYNEXIS Company Details
  • 12.10.2 Company Description and Business Overview
  • 12.10.3 Anti-fungal Drugs Introduction
  • 12.10.4 SCYNEXIS Revenue in Anti-fungal Drugs Business (2014-2019)
  • 12.10.5 SCYNEXIS Recent Development
• 12.11 Sanofi
• 12.12 Gilead Science
• 12.13 Enzon Pharmaceuticals

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Product (2019-2025)
• 13.2 Market Size Forecast by Application (2019-2025)
• 13.3 Market Size Forecast by Regions
• 13.4 North America
• 13.5 Europe
• 13.6 China
• 13.7 Japan
• 13.8 Southeast Asia
• 13.9 India
• 13.10 Central & South America

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

This report focuses on the global Anti-fungal Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-fungal Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Abbott Laboratories
Astellas Pharma
Bayer
GlaxoSmithKline
Glenmark
Kramer Laboratories
Merck
Novartis
Pfizer
SCYNEXIS
Sanofi
Gilead Science
Enzon Pharmaceuticals

Market segment by Type, the product can be split into
Powder
Ointment
Tablet
Other

Market segment by Application, split into
Hospital
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Anti-fungal Drugs status, future forecast, growth opportunity, key market and key players.
To present the Anti-fungal Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Anti-fungal Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.